unknown
Stage
1
Investors
About
Umlaut.bio develops a platform for discovering and developing next-generation biologics. It uses computational biology and high-throughput experimental techniques to engineer proteins with enhanced therapeutic properties.
Explore Umlaut.bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.